The National Lipid Assn. (NLA) released a draft summary that highlights key aspects of care that provide a thorough supplement and direction for clinicians treating patients with dyslipidemia.
May 14, 2014 — The Department of Health and Human Services (HHS) announced that new preliminary data show an overall 9 percent decrease in hospital-acquired conditions nationally during 2011 and 2012. National reductions in adverse drug events, falls, infections and other forms of hospital-induced harm are estimated to have prevented nearly 15,000 deaths in hospitals, avoided 560,000 patient injuries and approximately $4 billion in health spending over the same period.
May 14, 2014 — Data presented during Heart Rhythm 2014 found the use of quadripolar leads reduced the number of hospitalizations by 53 percent when compared to the non-quadripolar group. This hospitalization rate reduction translated into a statistically significant 62 percent reduction in overall costs for both healthcare systems and patients.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 14, 2014 — Vivek Reddy, M.D., director of arrhythmia services for The Mount Sinai Hospital, reported promising 12-month follow-up data showing the world's first leadless pacemaker is demonstrating overall device performance comparable to conventional pacemakers. Reddy presented the one-year LEADLESS study data findings during a late-breaking clinical trial presentation on Heart Rhythm 2014, the Heart Rhythm Society's (HRS) 35th annual scientific sessions in San Francisco.
May 14, 2014 — Detroit Medical Center (DMC) Harper Hospital presented a live CorPath robotic-assisted percutaneous coronary intervention (PCI), or coronary angioplasty, during the American College of Cardiology (ACC) annual meeting this year. The procedure, which was transmitted live to Washington, D.C., for meeting attendees, was led by Ted Schreiber, M.D., president of the Cardiovascular Institute and director of the Cardio One team at DMC Harper Hospital.
May 13, 2014 — The Heart Rhythm Society (HRS), American College of Cardiology (ACC) and American Heart Association (AHA) released Expert Consensus Statement on the Use of Implantable Cardioverter Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials at Heart Rhythm 2014, the 35th annual scientific sessions of HRS. The expert consensus statement provides first-of-its-kind guidance on ICD therapy for the management of patient populations who are not well represented in clinical trials and, as a result, not specifically included in existing guidelines.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Esaote North America received U.S. Food and Drug Administration (FDA) clearance to market and sell its Virtual Navigator fusion imaging technology for ultrasound to U.S. customers.
A Boston Scientific Corp. study demonstrated that outcomes for patients with the company's transvenous implantable cardioverter defibrillators (ICD) who received routine defibrillation testing (DT) at implant were similar to outcomes for those patients who did not receive defibrillation testing.
Elixir Medical Corp. received CE mark approval for its DESolve 100 Novolimus Eluting Bioresorbable Coronary Scaffold System.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 12, 2014 — Patients using the Boston Scientific Latitude remote patient management system with wireless telemetry demonstrated significantly lower mortality and fewer hospitalizations than patients with Latitude-compatible devices who were not followed on the system, according to results from the PREDICt-RM study (Patient RElated Determinants of ICD Remote Monitoring Utilization and Outcomes). The results were presented at Heart Rhythm 2014, the Heart Rhythm Society's (HRS) 35th annual scientific sessions in San Francisco.
May 12, 2014 — The Center for Magnetic Resonance Research (CMRR) at the University of Minnesota, Minneapolis, is the first U.S. facility to install Siemens Healthcare’s Magnetom Prisma, a 3T magnetic resonance imaging (MRI) scanner capable of exceptionally high spatial and temporal resolution to achieve image quality, particularly in highly demanding situations.
May 12 2014 — M*Modal announced enhancements to its Fluency Flex Mobile dictation application for iOS 6.0+ devices. Moving beyond the capture of clinical notes during patient encounters to more robust clinical documentation, the new application allows physicians to select a patient from their appointment schedule to quickly and accurately record clinical notes, improving ease of use and productivity.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The iCT Elite CT system provides low dose, low energy, and low noise with premium results. It is built on technologies ...
The Ingenuity Elite 256-slice CT scanner uses the NanoPanel Elite for low-dose, low-energy and low-noise imaging. It ...
The Philips Ingenuity Core CT scanner offers low-dose, high-quality imaging and coverage, and the ability to personalize image quality patient by patient. In addition, it offers in-room upgradability so its capabilities can grow as your needs grow. Key benefits of the system include confidence and consistency, high image quality with reduced artifacts, and industry-leading low-contrast resolution. The system comes in both 64 and 128 slice configurations. For more information: www.usa.philips.com/healthcare-products/HCNCTD320/ct-scanners-ingenuity-core-ct-scanner